Archive

Post Archive: Alex Spira MD PhD FACP

Ground breaking research leading to breakthroughs in cancer treatments - Timothy A. McCarthy, MD

July 11, 2022
Read More

Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial

June 27, 2022
Read More

Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting - Alexander I. Spira, MD, PhD, FACP

June 3, 2022
Read More

RESECTABLE NSCLC AND THE IMPORTANCE OF GUIDELINE-RECOMMENDED MOLECULAR TESTING

February 22, 2022
Read More

Journal of Clinical Oncology - ASCO Pub - Abstract - Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spria, MD, PhD, FACP

January 20, 2022
Read More

Virginia Cancer Specialists Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

October 11, 2021
Read More

Next Oncology Expands Phase I Program with Virginia Cancer Specialists Partnership

October 6, 2021
Read More

A monumental step forward in the treatment of non-small cell lung cancer patients harboring a KRAS mutation, Dr. Christina Brzezniak

June 16, 2021
Read More

Alexander I Spira, MD, PhD, FACP - Sotorasib for Lung Cancers with KRAS p.G12C Mutation, The New England Journal of Medicine

June 4, 2021
Read More

Exploring Why Testing in Lung Cancer is Important to Treatment Decisions - Alex Spira, MD, PhD, FACP

February 23, 2021
Read More